HOMCY CHARLES J enters MAZE THERAPEUTICS, INC. with 28.52K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 28.52K | Direct |
| Total | 28.52K | 28.52K direct |
Stock Option (Right to Buy)
DirectUnderlying shares
80.39K
Shares owned
N/A
Exercise price
10.42
Expiration
—
Exercise window
—
Series D-1 Preferred Stock
IndirectUnderlying shares
71.56K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
5.70K
Shares owned
N/A
Exercise price
10.42
Expiration
—
Exercise window
—
Series C Preferred Stock
DirectUnderlying shares
169.41K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
45.64K
Shares owned
N/A
Exercise price
10.42
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
46.67K
Shares owned
N/A
Exercise price
10.42
Expiration
—
Exercise window
—
Series B Preferred Stock
DirectUnderlying shares
72.73K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Underlying
492.10K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 10.42 | — | — | 80.39K | N/A |
| Series D-1 Preferred Stock Indirect | Common Stock | — | — | 71.56K | N/A | |
| Stock Option (Right to Buy) Direct | Common Stock | 10.42 | — | — | 5.70K | N/A |
| Series C Preferred Stock Direct | Common Stock | — | — | 169.41K | N/A | |
| Stock Option (Right to Buy) Direct | Common Stock | 10.42 | — | — | 45.64K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 10.42 | — | — | 46.67K | N/A |
| Series B Preferred Stock Direct | Common Stock | — | — | 72.73K | N/A | |
| Total | 492.10K | 0.00 | ||||